Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Endovia Health SciencesEDVA +3.56%20 Receivables Turnover is 0.00 as of Jun. 2026. GuruFocus rates EDVA with a GF Score™ of 20/100. The stock has 9 warning signs investors should review. Among 210 Beverages - Alcoholic companies, Endovia Health Sciences ranks worse than 99.52% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Endovia Health Sciences's Revenue for the
three
months ended in Jun. 2026 was $0.00 Mil. Endovia Health Sciences's average Accounts Receivable for the
three
months ended in Jun. 2026 was $0.02 Mil.
Endovia Health Sciences (AMEX:EDVA) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Endovia Health Sciences Receivables Turnover Related Terms
Endovia Health Sciences Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Endovia Health Sciences's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Endovia Health Sciences Receivables Turnover Chart
EDVA vs YHC, IBG, BF.B: Receivables Turnover Comparison
For the Beverages - Wineries & Distilleries subindustry, Endovia Health Sciences's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Endovia Health Sciences Receivables Turnover vs Beverages - Alcoholic Industry
For the Beverages - Alcoholic industry and Consumer Defensive sector, Endovia Health Sciences's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Endovia Health Sciences's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Endovia Health Sciences (EDVA) has a Receivables Turnover of 0.00 as of Jun. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Endovia Health Sciences and its competitors. According to the industry distribution chart, Endovia Health Sciences ranks #209 out of 210 companies in the Beverages - Alcoholic industry, placing it in the top 99.5%.
Is Endovia Health Sciences' Receivables Turnover too high?
Endovia Health Sciences' current Receivables Turnover is 0.00. Based on the distribution chart, Endovia Health Sciences ranks #209 out of 210 companies in the Beverages - Alcoholic industry, which is in the bottom quartile relative to peers. Overall, Endovia Health Sciences has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Endovia Health Sciences' Receivables Turnover compare to YHC and IBG?
According to the Beverages - Alcoholic industry distribution chart, Endovia Health Sciences ranks #209 out of 210 companies for Receivables Turnover. This places Endovia Health Sciences in the lower half of its industry. The industry median Receivables Turnover is 8.09. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Beverages - Alcoholic company?
The median Receivables Turnover among Beverages - Alcoholic companies is 8.09, based on 210 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Endovia Health Sciences and its competitors. For the Beverages - Alcoholic industry, the median Receivables Turnover is 8.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Endovia Health Sciences's current Receivables Turnover is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Endovia Health Sciences stock overvalued right now?
Endovia Health Sciences (EDVA) has a current Receivables Turnover of 0.00. The current Receivables Turnover is 0.00. Endovia Health Sciences' overall GF Score™ is 20/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Endovia Health Sciences (EDVA), the current Receivables Turnover is 0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Splash Beverage Group Inc is a portfolio company managing multiple brands across several growth segments within the consumer beverage industry. The company's two reportable operating segments are: (1) the manufacture and distribution of non-alcoholic and alcoholic beverages, and (2) the retail sale of beverages and groceries online. The company generates the majority of its revenue from the E-Commerce.
20GF Score
Get the complete analysis for EDVA
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
EDVA has been successfully added to your 
